Equities research analysts predict that GameStop (NYSE:GME) will announce $1.96 billion in sales for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for GameStop’s earnings. The highest sales estimate is $1.99 billion and the lowest is $1.88 billion. GameStop posted sales of $2.05 billion in the same quarter last year, which suggests a negative year-over-year growth rate of 4.4%. The business is expected to report its next quarterly earnings results after the market closes on Thursday, May 31st.
On average, analysts expect that GameStop will report full year sales of $8.86 billion for the current fiscal year, with estimates ranging from $8.80 billion to $8.89 billion. For the next fiscal year, analysts anticipate that the firm will report sales of $8.66 billion per share, with estimates ranging from $8.62 billion to $8.69 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of research analysts that follow GameStop.
Top 10 Growth Stocks For 2019: MEDIFAST INC(MED)
Advisors' Opinion:- [By Lisa Levin] Gainers Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) shares jumped 29.86 percent to close at $2.87 on Friday. Commercial Vehicle Group, Inc. (NASDAQ: CVGI) shares gained 28.87 percent to close at $8.75 after reporting upbeat Q1 earnings. Mexco Energy Corporation (NYSE: MXC) gained 27.02 percent to close at $5.4744. Carbon Black, Inc. (NASDAQ: CBLK) climbed 26 percent to close at $23.94. Carbon Black priced its IPO at $19 per share. Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) rose 25.64 percent to close at $42.44 after the FDA approved the company's Andexxa, the only antidote indicated for patients treated with rivaroxaban and apixaban. Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) rose 23.19 percent to close at $8.50 after reporting Q2 results. California Resources Corporation (NYSE: CRC) shares gained 22.45 percent to close at $31.58 following upbeat Q1 earnings. Atomera Incorporated (NASDAQ: ATOM) gained 22.31 percent to close at $6.25 after reporting Q1 results. Medifast, Inc. (NYSE: MED) shares jumped 22.27 percent to close at $121.46 after the company reported strong Q1 results and raised its FY18 guidance. Jerash Holdings (US), Inc. (NASDAQ: JRSH) gained 20.86 percent to close at $8.46. Pandora Media, Inc. (NYSE: P) rose 19.83 percent to close at $6.89 after reporting strong quarterly results. Shake Shack Inc (NYSE: SHAK) rose 18.01 percent to close at $55.95 on Friday after the company reported upbeat results for its first quarter and raised its FY18 guidance. Super Micro Computer, Inc. (NASDAQ: SMCI) rose 17.73 percent to close at $21.25 after reporting strong preliminary results for the third quarter. Schmitt Industries, Inc. (NASDAQ: SMIT) rose 17.41 percent to close at $2.36. Titan International, Inc. (NYSE: TWI) shares gained 16.78 percent to close at $12.25 following Q1 earnings. Integer Holdings Corporation (NYSE: ITGR) shares rose 14.23 percent to close at $63.40 following Q1 result
- [By Lisa Levin]
Medifast, Inc. (NYSE: MED) shares were also up, gaining 25 percent to $124.60 after the company reported strong Q1 results and raised its FY18 guidance.
- [By Max Byerly]
MediBloc (CURRENCY:MED) traded 0.2% lower against the U.S. dollar during the twenty-four hour period ending at 16:00 PM Eastern on June 7th. MediBloc has a total market cap of $37.92 million and $586,074.00 worth of MediBloc was traded on exchanges in the last 24 hours. Over the last week, MediBloc has traded down 36% against the U.S. dollar. One MediBloc token can now be purchased for $0.0128 or 0.00000166 BTC on major exchanges including Coinrail, Bibox and Gate.io.
- [By Logan Wallace]
MediBloc [QRC] (CURRENCY:MED) traded 11.6% lower against the US dollar during the 24 hour period ending at 20:00 PM Eastern on August 29th. One MediBloc [QRC] token can now be bought for about $0.0066 or 0.00000100 BTC on popular exchanges including Gate.io, Coinrail and Bibox. MediBloc [QRC] has a total market cap of $19.65 million and $279,707.00 worth of MediBloc [QRC] was traded on exchanges in the last 24 hours. During the last week, MediBloc [QRC] has traded 27.8% lower against the US dollar.
- [By Logan Wallace]
MediBloc [QRC20] (MED) is a proof-of-work (PoW) token that uses the HybridScryptHash256 hashing algorithm. It was first traded on January 3rd, 2014. MediBloc [QRC20]’s total supply is 4,097,545,844 tokens and its circulating supply is 2,966,384,100 tokens. MediBloc [QRC20]’s official website is medibloc.org/en. MediBloc [QRC20]’s official Twitter account is @MEDDevTeam. The official message board for MediBloc [QRC20] is medium.com/@MediBloc. The Reddit community for MediBloc [QRC20] is /r/MediBloc and the currency’s Github account can be viewed here.
Top 10 Growth Stocks For 2019: Buffalo Wild Wings Inc.(BWLD)
Advisors' Opinion:- [By Steve Symington]
That's not to say it was a quiet day for every stock on the market. With earnings season ramping up, brewing giant Anheuser-Busch InBev (NYSE:BUD) and restaurant chain Buffalo Wild Wings (NASDAQ:BWLD) served as an exercise in contrast as investors reacted to their respective quarterly reports.
- [By Peter Graham]
A long term performance chart shows Dave & Busters Entertainment tripling in value before falling back while small cap upscale gentlemen's clubs and restaurant owner RCI Hospitality Holdings, Inc (NASDAQ: RICK) began taking off in 2016 and small cap Buffalo Wild Wings (NASDAQ: BWLD) is being acquired by Arby's Restaurant Group:
Top 10 Growth Stocks For 2019: TrueBlue Inc.(TBI)
Advisors' Opinion:- [By Logan Wallace]
ValuEngine downgraded shares of Trueblue (NYSE:TBI) from a hold rating to a sell rating in a report issued on Friday morning.
Several other research firms have also recently weighed in on TBI. Zacks Investment Research cut shares of Trueblue from a hold rating to a sell rating in a research report on Tuesday, February 12th. BMO Capital Markets decreased their price objective on shares of Trueblue from $26.00 to $24.00 and set a market perform rating for the company in a research report on Monday, February 11th. TheStreet cut shares of Trueblue from a b- rating to a c rating in a research report on Monday, December 31st. Finally, Credit Suisse Group decreased their price objective on shares of Trueblue from $31.00 to $25.00 and set a hold rating for the company in a research report on Tuesday, November 6th. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the company. Trueblue presently has an average rating of Hold and a consensus price target of $26.00.
- [By Logan Wallace]
Media stories about Trueblue (NYSE:TBI) have trended somewhat positive on Monday, according to Accern Sentiment. The research firm rates the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Trueblue earned a media sentiment score of 0.09 on Accern’s scale. Accern also assigned media stories about the business services provider an impact score of 45.3296498009881 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
- [By Motley Fool Transcribers]
TrueBlue Inc (NYSE:TBI)Q4 2018 Earnings Conference CallFeb. 07, 2019, 5:00 p.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Stephan Byrd]
Russell Investments Group Ltd. grew its stake in Trueblue Inc (NYSE:TBI) by 21.2% during the first quarter, HoldingsChannel reports. The fund owned 137,178 shares of the business services provider’s stock after purchasing an additional 23,951 shares during the quarter. Russell Investments Group Ltd.’s holdings in Trueblue were worth $3,553,000 at the end of the most recent quarter.
Top 10 Growth Stocks For 2019: Intuitive Surgical Inc.(ISRG)
Advisors' Opinion:- [By Ethan Ryder]
Caisse DE Depot ET Placement DU Quebec decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 21.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,921 shares of the medical equipment provider’s stock after selling 520 shares during the period. Caisse DE Depot ET Placement DU Quebec’s holdings in Intuitive Surgical were worth $793,000 as of its most recent SEC filing.
- [By Keith Speights]
It isn't likely that Alphabet is concerned in the least about J&J's acquisition of Auris Health. But it could be a different story for the current leader in robotic surgery, Intuitive Surgical (NASDAQ:ISRG).
- [By Brian Feroldi]
TransEnterix (NYSEMKT:TRXC) recently surprised investors on the upside when it reported its first-quarter results. The company's Senhance surgical system is off to a fast start right out of the gate, and it has attracted a lot of positive attention from the medical community. This just goes to show how much demand is out there for an alternative to Intuitive Surgical's (NASDAQ: ISRG) dominant da Vinci platform.
- [By Brian Feroldi]
Mazor Robotics has been following in the footsteps of robotic-surgery granddaddy Intuitive Surgical (NASDAQ:ISRG) for years. However, Mazor knew that competing against the entrenched giant was going to be a losing battle, so it chose to focus on parts of the body that were left untouched by Intuitive's machines: the spine and brain.
Top 10 Growth Stocks For 2019: Nordstrom Inc.(JWN)
Advisors' Opinion:- [By Stephan Byrd]
Nordstrom (NYSE:JWN) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Nordstrom outperformed the industry in the last six months driven by the smooth execution of customer strategy and disciplined inventory management. The company has an impressive surprise history with earnings beat delivered in seven of the last eight quarters and topping sales estimates in three of the trailing four quarters. Results in first-quarter fiscal 2018 gained from the shift in Nordstrom’s loyalty event to the quarter compared with the second quarter in the prior year. Management raised the low-end of its EBIT and earnings views for fiscal 2018. Also, its focus on store expansion and strengthening capabilities through further investments, particularly in digital growth, remains noteworthy. However, investments toward occupancy, technology, supply chain and marketing are weighing on its margin performance for the last few quarters. Higher expenses have been resulting in higher SG&A expense, which is hurting profitability.”
- [By Chris Lange]
When Nordstrom Inc. (NYSE: JWN) reported its most recent quarterly results after the markets closed on Thursday, the department store chain said that it had $0.95 in earnings per share (EPS) and $4.07 billion in revenue. Consensus estimates had called for $0.84 in EPS and revenue of $3.96 billion. The fiscal second-quarter of last year reportedly had EPS of $0.65 and $3.79 billion in revenue.
- [By Steve Symington]
But several individual companies bucked the indexes' trend. Read on to learn why MiMedx Group (NASDAQ:MDXG), Core Laboratories (NYSE:CLB), and Nordstrom (NYSE:JWN) trailed the broader market today.
- [By Benzinga News Desk]
Dan Loeb is looking to play in the emerging financial technology space. The hedge fund manager behind Third Point is looking to raise $400 million for Far Point Acquisition Corp., a so-called “blank check” acquisition company, he revealed in a regulatory filing: Link
ECONOMIC DATA The flash Composite Purchasing Managers' Index for May will be released at 9:45 a.m. ET. New home sales report for April is schedule for release at 10:00 a.m. ET. The Energy Information Administration’s weekly report on petroleum inventories in the U.S. will be released at 10:30 a.m. ET. The Treasury is set to auction 5-year notes at 1:00 p.m. ET. The Federal Open Market Committee will issue minutes of its meeting at 2:00 p.m. ET. Minneapolis Federal Reserve President Neel Kashkari is set to speak at 2:15 p.m. ET. ANALYST RATINGS Deutsche Bank upgrades Nordstrom (NYSE: JWN) to Buy from Hold; Raises Price Target to $55 from $52 Bernstein upgrades Celgene (NASDAQ: CELG) to Outperform Longbow Research downgrades Shake Shack (NYSE: SHAK) to Neutral Stifel downgrades Red Robin Gourmet Burgers (NASDAQ: RRGB) to Hold, Lowers Price Target to $55This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.
No comments:
Post a Comment